OTC/Supplement Combo New Safety/Efficacy Data Not Needed - Attorney Hutt
This article was originally published in The Tan Sheet
Executive Summary
OTC/supplement combination products do not require premarket clinical trials to establish safety and efficacy if data exist on the individual ingredients, attorney Peter Barton Hutt of Covington & Burling (Washington, D.C.) asserted at the Consumer Healthcare Products Association Legal & Regulatory Conference in D.C. Nov. 30.